Sight Sciences Inc
NASDAQ:SGHT

Watchlist Manager
Sight Sciences Inc Logo
Sight Sciences Inc
NASDAQ:SGHT
Watchlist
Price: 4.66 USD -10.56%
Market Cap: 234.4m USD
Have any thoughts about
Sight Sciences Inc?
Write Note

Sight Sciences Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sight Sciences Inc
Cash Equivalents Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Sight Sciences Inc
NASDAQ:SGHT
Cash Equivalents
$138.1m
CAGR 3-Years
31%
CAGR 5-Years
101%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash Equivalents
$4.5B
CAGR 3-Years
12%
CAGR 5-Years
54%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Cash Equivalents
$2.5B
CAGR 3-Years
9%
CAGR 5-Years
55%
CAGR 10-Years
26%
Stryker Corp
NYSE:SYK
Cash Equivalents
$3.9B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Cash Equivalents
$7B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash Equivalents
$1.8B
CAGR 3-Years
32%
CAGR 5-Years
23%
CAGR 10-Years
14%

See Also

What is Sight Sciences Inc's Cash Equivalents?
Cash Equivalents
138.1m USD

Based on the financial report for Dec 31, 2023, Sight Sciences Inc's Cash Equivalents amounts to 138.1m USD.

What is Sight Sciences Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
101%

Over the last year, the Cash Equivalents growth was -25%. The average annual Cash Equivalents growth rates for Sight Sciences Inc have been 31% over the past three years , 101% over the past five years .

Back to Top